A thriving global commercial footprint

Martindale Pharma’s ability to produce essential medicines with a focus on Emergency Care in our modern, efficient in-house sterile injection based manufacturing facility allows us to supply our products to fast growing, developing countries which are seeking EU-supplied products for hospitals.

Working with an expert logistics provider in Laborex in Africa, Martindale Pharma has a growing business currently centred on South Africa, Kenya, Sudan and Tanzania and is set to expand into other English-speaking parts of this exciting and vibrant market for medicines.

In Australia we have an established partnership with Link Pharmaceuticals (now part of Clinigen) focussed on our Hospital-initiated Medicines. We have also embarked on a strategic partnership in Sri Lanka and have a number of products on contact to hospitals with a series of additional products in the process of regulatory approval. In total Martindale Pharma sells medicines from our portfolio to over 20 additional countries across the globe, including New Zealand, Singapore, France, Germany.

We see a clear opportunity in our ability to supply essential medicines in a sterile ampoule format to international markets. We have established trading relationships with non-governmental organisations such as Medecins Sans Frontieres, supplying our Emergency Care range and we are actively looking to expand our share of this market given our ability to manufacture high quality generic injectable products from our UK facility.

Download our terms and conditions for the sale of goods.

Middle East Sales and Customer Services

t +44 (0) 1277 235331
e sales
e customer service